Related Experiment Videos
[Malignant tumors of unknown origin]
H Rezaei Kalantari1, G Jerusalem, V Bours
1Université de Liège, Département de Médecine.
Revue Medicale De Liege
|March 19, 1999
Summary
Cancers of unknown primary origin require biopsies for diagnosis, guiding therapy. While some patients benefit from targeted treatments, others face aggressive tumors with poor prognoses and limited therapeutic options.
Area of Science:
- Oncology
- Pathology
Context:
- Cancers of unknown primary origin present a unique clinical challenge.
- Diagnostic strategies must align with available therapeutic interventions.
Purpose:
- To outline diagnostic approaches for cancers of unknown primary origin.
- To identify patient groups with distinct prognoses and treatment possibilities.
Summary:
- Biopsy is essential for diagnosis, with immunohistology, electron microscopy, and cytogenetics aiding in identifying carcinomas and poorly differentiated adenocarcinomas.
- Clinical status and histology help stratify patients.
- Patients are categorized into those who can benefit from specific therapies and those with severe prognoses and aggressive tumors.
Impact:
- Facilitates tailored treatment strategies for specific patient subgroups.
- Highlights the need for improved therapies for aggressive, undiagnosed cancers.
- Improves understanding of the clinical behavior of cancers of unknown origin.